Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
NCT07754981
Self-Help Booklets for Sleep in Adults With Pulmonary HypertensionUniversity of SheffieldNot Yet RecruitingNot Applicable
NCT07754981Not Yet Recruiting
Not Applicable
Self-Help Booklets for Sleep in Adults With Pulmonary HypertensionUniversity of Sheffield
NCT07755241
A Study of AC-101 Tablets in Patients With Ulcerative ColitisAccro Bioscience (Suzhou) LimitedNot Yet RecruitingPhase 2
NCT07755241Not Yet Recruiting
Phase 2
A Study of AC-101 Tablets in Patients With Ulcerative ColitisAccro Bioscience (Suzhou)...
NCT07754422
Bladder Meridian Gua Sha for Lumbar Disc Herniation: Efficacy and CRP Regulation Via Cutaneous-Meridian-Visceral Axis in Shen PeriodGuangdong Provincial Hospital of Traditional Chinese MedicineCompletedNot Applicable
NCT07754422Completed
Not Applicable
Bladder Meridian Gua Sha for Lumbar Disc Herniation: Efficacy and CRP Regulation...Guangdong Provincial Hosp...
NCT07754175
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a TrialKang Stem Biotech Co., Ltd.Recruiting
NCT07754175Recruiting
—
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and...Kang Stem Biotech Co., Lt...
NCT07755488
Change in Shoe Size and Forefoot Morphological Parameters After Scarf + P1 Osteotomy for Hallux Valgus: a Prospective Study Using Surface 3D ScanningGroupe Hospitalier Diaconesses Croix Saint-SimonNot Yet RecruitingNot Applicable
NCT07755488Not Yet Recruiting
Not Applicable
Change in Shoe Size and Forefoot Morphological Parameters After Scarf + P1 Osteo...Groupe Hospitalier Diacon...
NCT07756567
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for PsychosisNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07756567Not Yet Recruiting
Not Applicable
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Cl...National Institute of Men...
NCT07755644
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07755644Not Yet Recruiting
Not Applicable
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk University
NCT07754630
Analysis of the Hormonal Implant and Transdermal Estradiol Gel in Climacteric WomenNutrindo Ideais Research CenterActive Not RecruitingPhase 2
NCT07754630Active Not Recruiting
Phase 2
Analysis of the Hormonal Implant and Transdermal Estradiol Gel in Climacteric Wo...Nutrindo Ideais Research...
NCT07754123
Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCJiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 3
NCT07754123Not Yet Recruiting
Phase 3
Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patien...Jiangsu Hansoh Pharmaceut...
NCT07754786
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic DermatitisInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 3
NCT07754786Not Yet Recruiting
Phase 3
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Partic...Innovent Biologics (Suzho...
NCT07753837
Web-based Acceptance and Commitment Therapy (ACT) Intervention for University StudentsNational University of Modern LanguagesCompletedNot Applicable
NCT07753837Completed
Not Applicable
Web-based Acceptance and Commitment Therapy (ACT) Intervention for University St...National University of Mo...
NCT07754773
Motus Nova Foot Device for Patients With HemiplegiaMultiCare Health System Research InstituteNot Yet RecruitingNot Applicable
NCT07754773Not Yet Recruiting
Not Applicable
Motus Nova Foot Device for Patients With HemiplegiaMultiCare Health System R...
NCT07755540
Group Music Therapy for Chronic Pain Management in Active Duty Service Members: A Randomized Controlled TrialDrexel UniversityRecruitingPhase 2
NCT07755540Recruiting
Phase 2
Group Music Therapy for Chronic Pain Management in Active Duty Service Members:...Drexel University
NCT07755345
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Young Male Soccer PlayersIstanbul Gelisim UniversityCompletedNot Applicable
NCT07755345Completed
Not Applicable
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Y...Istanbul Gelisim Universi...
NCT07755813
Pirfenidone as Treatment of Chronic PancreatitisUnited States Department of DefenseNot Yet RecruitingPhase 2
NCT07755813Not Yet Recruiting
Phase 2
Pirfenidone as Treatment of Chronic PancreatitisUnited States Department...
NCT07754058
External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Primary Acquired Nasolacrimal Duct ObstructionMilitary Institute od Medicine National Research InstituteCompletedNot Applicable
NCT07754058Completed
Not Applicable
External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Pr...Military Institute od Med...
NCT07755397
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands TumorJubilant Therapeutics India LimitedRecruitingPhase 1
NCT07755397Recruiting
Phase 1
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Stud...Jubilant Therapeutics Ind...
NCT07755436
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.ArriVent BioPharma, Inc.RecruitingPhase 1
NCT07755436Recruiting
Phase 1
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity,...ArriVent BioPharma, Inc.
Result Breakdown
Not yet recruiting9 (45%)
Recruiting6 (30%)
Completed4 (20%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Phase 24 (20%)
Phase 32 (10%)
Phase 12 (10%)
Not Specified1 (5%)